Patent intelligence · DE
DE 69131398
VERWENDUNG VON 5-HT4 REZEPTORANTAGONISTEN ZUR BEHANDLUNG VON VORHOF-FIBRILLATION UND ZUR VORBEUGUNG VON SCHLAGANFALL
VERWENDUNG VON 5-HT4 REZEPTORANTAGONISTEN ZUR BEHANDLUNG VON VORHOF-FIBRILLATION UND ZUR VORBEUGUNG VON SCHLAGANFALL
Patent details — DE 69131398
- Jurisdiction
- DE
- Status
- expired
- Grant date
- Mar 2, 2000
- Expiration
- Feb 26, 2020
- Applicant
- SMITH KLINE FRENCH LAB [GB]
- CPC classes
- A61K 9/ 20 A I, A61K 9/ 48 A I, A61K 31/ 00 A I, A61K 31/ 46 A I
Quick answer
DE 69131398 (VERWENDUNG VON 5-HT4 REZEPTORANTAGONISTEN ZUR BEHANDLUNG VON VORHOF-FIBRILLATION UND ZUR VORBEUGUNG VON SCHLAGANFALL) is held by SMITH KLINE FRENCH LAB [GB]. Status: expired. Granted Mar 2, 2000. Expires Feb 26, 2020 (0 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- SMITH KLINE FRENCH LAB [GB]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 9/ 20 A I, A61K 9/ 48 A I, A61K 31/ 00 A I, A61K 31/ 46 A I, A61K 31/ 439 A I, A61K 45/ 00 A I
More from SMITH KLINE FRENCH LAB [GB]
Related pharmaceutical patents in our USPTO index.
-
SA 92120308
تركيبة للاستخدام الموضعي topical composition
expired -
AT E269330
CHEMISCHE VERBINDUNGEN
expired -
EP 1425277
HARNSTOFF-DERIVATE ALS VANILLOID-REZEPTOR-ANTAGONISTEN FÜR DIE SCHMERZBEHANDLUNG
expired -
SA 91110341
مستحضر موضعي لعلاج العدوى بفيروس الحلا (القوباء) Herpesvirus
expired -
HU P0302480
PYRIDINONE DERIVATIVES FOR TREATMENT OF ATHEROSCLEROSIS, PROCESS FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
expired -
AT E245157
3,9-DIAZABICYCLO-(3.3.1)-NONANYLDERIVATE, VERFAHREN UND INTERMEDIATE FÜR IHRE DARSTELLUNG UND SIE ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN
expired -
HK 1004528
Dentifrice compositions
expired -
HU P0204410
PYRIMIDINE-4-ONE DERIVATIVES, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE
expired
Frequently asked questions
What is US patent 69131398?
DE 69131398 (VERWENDUNG VON 5-HT4 REZEPTORANTAGONISTEN ZUR BEHANDLUNG VON VORHOF-FIBRILLATION UND ZUR VORBEUGUNG VON SCHLAGANFALL) is held by SMITH KLINE FRENCH LAB [GB]. Status: expired. Granted Mar 2, 2000. Expires Feb 26, 2020 (0 years remaining) — relevant for patent-cliff and LOE planning.
Who owns DE 69131398?
SMITH KLINE FRENCH LAB [GB] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 25 pharmaceutical patents for this assignee.
When does DE 69131398 expire?
Our index shows an expiration date of Feb 26, 2020 (0 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.